The Science of Extrapolation – Martina Weise, EBG Biosimilars 2015, London (PPT)

To view the full presentation, please click here.

Part I of II

Part II of II

The off-patent medicines industry is a vital part of the… 30 June 2022 Health systems face tremendous challenges across Europe. The management of…
European patients need improved access to biosimilar… 22 April 2021 Fifteen years after the first global approval, biosimilar medicines systemically…
Positioning Statements on Physician-led Switching for… 1 October 2021 Positioning statements on physician-led switching for biosimilar medicines (October 2021)…
IGBA Calls on all Stakeholders to Join the Biosimilars… 1 November 2021 Read more